Multicharacteristic Opsin (MCO)-I
Showing 1 - 25 of >10,000
Study in Subjects Who Received vMCO-I Administered Via
Enrolling by invitation
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023
Retinitis Pigmentosa, Retinal Diseases, Retinal Degeneration Trial in Cuttack (Gene Therapy product:vMCO-I)
Completed
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 2, 2021
Stargardt Disease Trial in Miami, McAllen (Gene Therapy-vMCO-010)
Active, not recruiting
- Stargardt Disease
- Gene Therapy-vMCO-010
-
Miami, Florida
- +1 more
Nov 28, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Tumors,Colorectal Trial in Moscow (Stoma formation, Endoscopic self-expandable metal stent placement)
Recruiting
- Neoplasms,Colorectal
- Stoma formation
- Endoscopic self-expandable metal stent placement
-
Moscow, Russian FederationClinic of colorectal and minimally invasive surgery University H
Dec 1, 2022
MDD, Inflammation Trial in Duffel, Brussels, Leuven (Celecoxib, Minocyclin, Placebo)
Not yet recruiting
- Major Depressive Disorder
- Inflammation
- Celecoxib
- +2 more
-
Duffel, Antwerpen, Belgium
- +2 more
Dec 8, 2022
Terminal Renal Insufficiency Trial in Quincy-sous-Sénart (Questionnaire "recovery time after a dialysis session"., SF-12
Recruiting
- Terminal Renal Insufficiency
- Questionnaire "recovery time after a dialysis session".
- +5 more
-
Quincy-sous-Sénart, FranceHôpital Privé Claude Galien
Jan 10, 2023
Troponin T Trial in Graz (Theranova 400, FX 10, FX CorDiax 800)
Not yet recruiting
- Troponin T
- Theranova 400
- +3 more
-
Graz, AustriaMedical University of Graz
Jun 27, 2022
Suicide and Self-harm Trial (Caring Contacts letters, Reports, re-engagement, and training)
Not yet recruiting
- Suicide and Self-harm
- Caring Contacts letters
- Reports, re-engagement, and training
- (no location specified)
Oct 11, 2022
Dietary Diversity of Young Children During CoVID-19 Outbreak: A
Completed
- Dietary Diversity
- Dietary counselling on Food Groups according to IYC Feeding practices, WHO
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaUniversity of Malaya Medical Center
Oct 31, 2022
End Stage Renal Failure on Dialysis Trial in Hong Kong (High-flux dialyzer, Theranova dialyzer)
Completed
- End Stage Renal Failure on Dialysis
- High-flux dialyzer
- Theranova dialyzer
-
Hong Kong, Hong Kong
- +1 more
Sep 28, 2021
Chronic Kidney Failure, Chronic Inflammation Trial in Halle, Berlin (MCO-Ci 400, Revaclear 400)
Completed
- Chronic Kidney Failure
- Chronic Inflammation
- MCO-Ci 400
- Revaclear 400
-
Halle, Sachsen-Anhalt, Germany
- +1 more
Feb 17, 2022
Depressive Disorder, Major, Bipolar Disorder, Schizo Affective Disorder Trial in San Antonio (CAT, R-CAT)
Recruiting
- Depressive Disorder, Major
- +3 more
- CAT
- R-CAT
-
San Antonio, TexasUniversity of Texas Health Science Center - Department of Psychi
Mar 29, 2022
Frail Elderly Syndrome, Heart Failure Trial (PRESAGE CARE)
Not yet recruiting
- Frail Elderly Syndrome
- Heart Failure
- PRESAGE CARE
- (no location specified)
Aug 25, 2023
End Stage Renal Disease (ESRD) Trial in Poitiers, Saint-Benoît (Hemodialysis sessions)
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Hemodialysis sessions
-
Poitiers, France
- +1 more
May 2, 2022
End Stage Renal Disease (ESRD) Trial in Poitiers (Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™)
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™) dialyzer
-
Poitiers, FranceCHU de Poitiers
Jan 12, 2023
Physical Activity and Mental Health During and After Covid-19
Completed
- University Students
- No intervention will be used.
-
Kajang, Selangor, MalaysiaUniversiti Tunku Abdul Rahman
Feb 6, 2022
Autosomal Dominant Retinitis Pigmentosa (adRP)
Terminated
- Retinitis Pigmentosa
- Observation
-
Dallas, TexasTexas Retina Associates,
Mar 15, 2021
Contraception Trial (quationaire)
Not yet recruiting
- Contraception
- quationaire
- (no location specified)
Jun 6, 2023
Atrial Fibrillation, Anticoagulants Trial (Use of "I-Anticoagulation" to make the decision and manage patients)
Not yet recruiting
- Atrial Fibrillation
- Anticoagulants
- Use of "I-Anticoagulation" to make the decision and manage patients
- (no location specified)
Nov 14, 2023
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023
Insomnia Trial (Web-based Cognitive Behavioral Therapy for Insomnia (wCBT-I)
Not yet recruiting
- Insomnia
- Web-based Cognitive Behavioral Therapy for Insomnia (wCBT-I
- (no location specified)
Aug 16, 2023
Multiple Sclerosis, Insomnia Trial (Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I), Digital patient education about
Not yet recruiting
- Multiple Sclerosis
- Insomnia
- Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
- Digital patient education about insomnia (PE)
- (no location specified)
Oct 27, 2023
Advanced Solid Tumor Trial in Beijing (Simmitinib, SG001)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaCancer Hospital,Chinese Academy of Medical Sciences and Peking U
Nov 9, 2023
Heart Failure Trial in New York (I-TRANSFER-HF)
Not yet recruiting
- Heart Failure
- I-TRANSFER-HF
-
New York, New York
- +1 more
Oct 31, 2023